S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs

Research Frontiers (REFR) Insider Trading & Ownership

$1.05
-0.02 (-1.87%)
(As of 11/27/2023 ET)
Compare
Today's Range
$1.05
▼
$1.10
50-Day Range
$1.00
▼
$1.27
52-Week Range
$0.91
▼
$2.42
Volume
36,625 shs
Average Volume
32,521 shs
Market Capitalization
$35.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Research Frontiers (NASDAQ:REFR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.16%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$23,681.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get REFR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Research Frontiers stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

REFR Insider Buying and Selling by Quarter


Research Frontiers Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2023Darryl DaigleDirectorBuy500$1.05$525.00  
9/13/2023Darryl DaigleDirectorBuy1,600$1.35$2,160.00  
6/15/2023Darryl DaigleDirectorBuy4,400$1.59$6,996.00  
2/9/2023Darryl DaigleDirectorBuy3,500$2.00$7,000.00  
1/25/2023Darryl DaigleDirectorBuy3,500$2.00$7,000.00  
(Data available from 1/1/2013 forward)












REFR Insider Trading Activity - Frequently Asked Questions

Who is on Research Frontiers's Insider Roster?

The list of insiders at Research Frontiers includes Darryl Daigle. Learn more on insiders at REFR.

What percentage of Research Frontiers stock is owned by insiders?

6.16% of Research Frontiers stock is owned by insiders. Learn more on REFR's insider holdings.

Which Research Frontiers insiders have been buying company stock?

The following insider purchased REFR shares in the last 24 months: Darryl Daigle ($23,681.00).

How much insider buying is happening at Research Frontiers?

Insiders have purchased a total of 13,500 REFR shares in the last 24 months for a total of $23,681.00 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:REFR) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -